Chemung Financial (CMHG) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Apr, 2026Executive summary
Annual Meeting scheduled for June 2, 2026, to be held virtually; record date is April 6, 2026.
Shareholders will vote on director elections, executive compensation (Say-on-Pay), and auditor ratification.
Proxy materials are primarily distributed electronically to reduce costs and environmental impact.
4,819,440 shares of common stock are outstanding, each entitled to one vote.
Voting matters and shareholder proposals
Four directors are nominated for three-year terms expiring in 2029: Richard E. Forrestel Jr., Stephen M. Lounsberry III, Anders M. Tomson, and G. Thomas Tranter Jr.
Advisory vote on executive compensation (Say-on-Pay) is proposed, with Board recommending approval.
Ratification of Crowe LLP as independent auditor for 2026 is recommended.
No additional shareholder proposals will be considered at the 2026 meeting; deadlines for 2027 proposals are specified.
Board of directors and corporate governance
Board consists of 13 members, divided into three classes with staggered three-year terms.
Majority of directors are independent; CEO and Chairman roles are separated.
Board refreshment emphasized, with over half of directors joining since 2016.
Three standing committees: Audit, Nominating and Governance, and Compensation and Personnel, all comprised of independent directors.
Board and committee charters, codes of ethics, and governance guidelines are publicly available.
Latest events from Chemung Financial
- Q2 2026 net income rose to $8.8M, driven by loan growth, margin expansion, and improved asset quality.CMHG
Q2 2026 - All proposals, including director elections and compensation, were approved by majority vote.CMHG
AGM 2025 - All proposals passed, including director elections and auditor ratification for 2026.CMHG
AGM 2026 - Votes on directors, executive pay, and auditor ratification set for June 2026 meeting.CMHG
Proxy filing - Record Q1 2026 net income of $9.2M and improved efficiency driven by loan growth and expansion.CMHG
Q1 2026 - Robust loan growth, margin expansion, and capital strength drive continued strategic momentum.CMHG
Investor presentation - Annual non-GAAP net income rose 17.8% to $27.9M, driven by strong loan growth and margin gains.CMHG
Q4 2025 - Board recommends FOR all proposals, including director elections and new equity plan.CMHG
Proxy Filing - All proposals passed; strong 2023 results, expansion, and dividends highlighted.CMHG
AGM 2024